Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Scientific Reports|February 3, 2021
Neuroendocrine prostate cancer has distinctive, non-prostatic HOX code that is represented by the loss of HOXB13 expressionSiyuan Cheng, Shu Yang, Yingli Shi, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Unveiling Novel Double-Negative Prostate Cancer Subtypes Through Single-Cell RNA Sequencing AnalysisSiyuan Cheng, Lin Li, Yunshin Yeh, et al.
NPJ Precision Oncology|August 2, 2024
Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysisSiyuan Cheng, Lin Li, Yunshin Yeh, et al.
Advances in Experimental Medicine and Biology|January 5, 2020
Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy ResistanceYunshin Yeh, Qiaozhi Guo, Zachary Connelly, et al.
American Journal of Clinical and Experimental Urology|December 5, 2018
Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumorsZachary M Connelly, Shu Yang, Fenghua Chen, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissuesLin Li, Siyuan Cheng, Yunshin Yeh, et al.
Frontiers in Oncology|April 29, 2024
The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissuesLin Li, Siyuan Cheng, Yunshin Yeh, et al.
Prostate Cancer and Prostatic Diseases|April 22, 2020
The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancerSiyuan Cheng, Nestor Prieto-Dominguez, Shu Yang, et al.
Pageof 1